US Broker Ratings

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 69% Upside Potential with Strong Buy Ratings

Arcellx, Inc. (NASDAQ: ACLX) is a promising player in the biotechnology sector, primarily focused on breakthrough immunotherapies for cancer and other formidable diseases. This U.S.-based company,..

Disc Medicine, Inc. (IRON): Analyst Consensus and 84% Upside Potential Ignite Investor Interest

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company based in Watertown, Massachusetts, is gaining attention in the investment community, particularly among those focused on biotechnology..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a Potential 103% Upside

For investors with an appetite for high-risk, high-reward opportunities, Novavax, Inc. (NASDAQ: NVAX) offers a compelling narrative. With a potential upside of 103.16% based on analyst..

Bausch Health Companies Inc. (BHC) Stock Analysis: Navigating a 3.11% Potential Upside with Strategic Insights

Bausch Health Companies Inc. (NYSE: BHC) represents an intriguing opportunity in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Significant Upside Potential with an 87% Increase Forecasted

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a prominent player in the biotechnology sector, is gaining notable attention from investors due to its innovative approach in treating severe..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 126.82% Potential Upside Amidst Strong Buy Ratings

Ultragenyx Pharmaceutical Inc. (RARE), a prominent player in the biotechnology sector, is making waves with its focus on rare and ultra-rare genetic diseases. Headquartered in Novato,..

Indivior PLC (INDV) Investor Outlook: Exploring a 22% Potential Upside with Robust Analyst Confidence

Indivior PLC (INDV), a key player in the healthcare sector, is gaining attention with a compelling 22.19% potential upside. Situated within the Drug Manufacturers – Specialty..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Exploring a 141% Potential Upside in the Biotech Sector

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stands out in the biotechnology sector with a promising portfolio of targeted oncology therapeutics. With a market capitalization of $1.85 billion,..

Alignment Healthcare, Inc. (ALHC) Growth Potential: Analyst Ratings and a 38.68% Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC), a prominent player in the healthcare sector specializing in Medicare Advantage plans, is capturing investor attention with its remarkable growth prospects..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Navigating Uncharted Territory with a $1.06 Billion Market Cap

Pulse Biosciences, Inc. (NASDAQ: PLSE) stands out in the healthcare sector, specifically within the medical instruments and supplies industry, with its innovative approach to bioelectric medicine...

Certara, Inc. (CERT) Stock Analysis: Navigating a 44% Potential Upside in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Certara, Inc. (NASDAQ: CERT) represents an intriguing opportunity, particularly given its potential upside of 44.35% based..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Exploring the 73.52% Potential Upside in Biotech

For investors with an eye toward the biotechnology sector, Xenon Pharmaceuticals Inc. (NASDAQ: XENE) presents a compelling case, not just for its innovative pipeline but also..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 25% Upside Potential

ANI Pharmaceuticals, Inc. (ANIP) is a standout player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Baudette, Minnesota, this..

Select Medical Holdings Corp (SEM) Stock Analysis: Eyeing a 38% Potential Upside with Robust Analyst Ratings

Select Medical Holdings Corporation (NYSE: SEM) has emerged as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Evaluating the 125% Upside Potential

Investors are always on the lookout for promising opportunities in the healthcare sector, and Dynavax Technologies Corporation (NASDAQ: DVAX) has been catching eyes with its substantial..

CONMED Corporation (CNMD) Stock Analysis: Exploring a Potential 28% Upside in the Medical Devices Sector

CONMED Corporation, trading under the ticker CNMD, stands as a noteworthy player in the medical devices sector within the healthcare industry. With a market capitalization of..

Artivion, Inc. (AORT) Stock Analysis: A Promising Buy With 8% Upside Potential

Artivion, Inc. (AORT), a significant player in the medical devices sector, presents a compelling opportunity for investors seeking growth in the healthcare industry. With a market..

Agios Pharmaceuticals (AGIO) Stock Analysis: A 46.87% Upside in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 46.87%, according to analyst ratings...

Vera Therapeutics (VERA): Investor Outlook Highlights Potential 175% Upside in Transformative Biotech Arena

Vera Therapeutics, Inc. (NASDAQ: VERA) stands at the forefront of innovation in the healthcare sector, specifically within biotechnology. Based in Brisbane, California, this clinical-stage company focuses..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds